0260B |
Alprazolam, Blood |
0260FL |
Alprazolam, Fluid |
0260SP |
Alprazolam, Serum/Plasma |
0260TI |
Alprazolam, Tissue |
1080B |
Chlordiazepoxide and Metabolite, Blood |
1080SP |
Chlordiazepoxide and Metabolite, Serum/Plasma |
1080U |
Chlordiazepoxide and Metabolite, Urine |
1267B |
Clobazam, Blood |
1267U |
Clobazam, Urine |
3216B |
Nordiazepam and Metabolite, Blood |
3216SP |
Nordiazepam and Metabolite, Serum/Plasma |
3216U |
Nordiazepam and Metabolite, Urine |
3260B |
Oxazepam, Blood |
3260SP |
Oxazepam, Serum/Plasma |
3260U |
Oxazepam, Urine |
3580B |
Phenobarbital, Blood |
3581SP |
Phenobarbital - Unbound, Serum/Plasma |
3582SP |
Phenobarbital - Total/Unbound/Bound, Serum/Plasma |
3900B |
Primidone, Phenobarbital and PEMA, Blood |
3900FL |
Primidone, Phenobarbital and PEMA, Fluid |
8646B |
Alprazolam and Metabolite, Blood |
8646FL |
Alprazolam and Metabolite, Fluid |
8646SP |
Alprazolam and Metabolite, Serum/Plasma |
8646U |
Alprazolam and Metabolite, Urine |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9416B |
Phenobarbital Screen, Blood |